Phase 3 Colorectal Cancer Trial, Recruiting NCT06609551 Sponsor: Zhejiang Cancer Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Phase 3 Colorectal Cancer Trial, Recruiting

NCT06609551
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 70 and 80 years old, both men and women
  • People who have been confirmed through laboratory tissue testing to have stage II high-risk or stage III colon cancer
  • People with an ECOG performance score of 2 or less (this is a measure of how much a person's cancer affects their daily activities — confirm with trial site)
  • People who are able to have tissue genetic testing performed
  • People who are willing to take part voluntarily, sign a consent form, follow the study requirements, and attend follow-up visits

Who may not be able to join:

  • People who have one or more serious ongoing health conditions that, in the opinion of the trial doctor, would prevent them from completing the study
  • People who have had any other type of cancer diagnosed within the past 5 years
  • People with any unstable or poorly controlled health condition, including active infection, poorly controlled diabetes, poorly controlled high blood pressure, unstable chest pain, heart failure, a heart attack within the past year, serious irregular heartbeat requiring medication, or significant liver, kidney, or metabolic disease
  • People living with a serious mental health condition
  • People who have taken part in another clinical trial within the 30 days before the screening visit
  • People who are unable to receive adjuvant chemotherapy (a course of cancer-fighting medication given after surgery)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 86-0571-88128011

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Zhejiang Cancer Hospital
Registry
ClinicalTrials.gov
Start date
3 July 2024
Est. completion
31 December 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

2-year DFS (Disease-Free Survival)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov